Literature DB >> 21997284

Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus.

I Kanazawa1, T Yamaguchi, T Sugimoto.   

Abstract

BACKGROUND: Although accumulating evidence shows that aging hormones are involved in glucose metabolism, effects of glycemic control on serum IGF-I and DHEAS levels are still unclear. OBJECTIVE AND METHODS: To investigate the effects of glycemic control on these hormone levels, we conducted a 1-month longitudinal study of 49 Japanese patients with Type 2 diabetes mellitus. We measured serum levels of IGF-I and DHEA-S before and after 1-month glycemic control and analyzed the association of changes in IGF-I and DHEA-S with glycated hemoglobin (HbA1c).
RESULTS: HbA1c was decreased at 1 month with mean changes of -1.2% (p<0.001). Serum IGF-I was increased with mean changes of 11 ng/ml (p<0.05), while serum DHEA-S was decreased with mean changes of -19 μg/dl (p<0.05). Multiple regression analysis showed that changes in DHEA-S were inversely associated with changes in fasting plasma glucose (β=-0.36, p=0.027) and HbA1c (β=-0.33, p=0.028), while changes in IGF-I were not.
CONCLUSION: The present longitudinal study showed that intensive glycemic control for 1 month increased serum IGF-I level and decreased serum DHEA-S level in Japanese patients with poorly controlled Type 2 diabetes. Further studies are needed to clarify the hormonal changes in IGF-I and DHEA-S after intensive glycemic control would affect diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997284     DOI: 10.3275/8033

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.

Authors:  T Sugimoto; K Nishiyama; F Kuribayashi; K Chihara
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

Review 2.  Hormonal and nutritional regulation of IGF-I and its binding proteins.

Authors:  L E Underwood; J P Thissen; S Lemozy; J M Ketelslegers; D R Clemmons
Journal:  Horm Res       Date:  1994

3.  Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people.

Authors:  G Paolisso; M R Tagliamonte; M R Rizzo; C Carella; A Gambardella; M Barbieri; M Varricchio
Journal:  J Am Geriatr Soc       Date:  1999-11       Impact factor: 5.562

4.  Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease.

Authors:  Michiaki Fukui; Yoshihiro Kitagawa; Naoto Nakamura; Mayuko Kadono; Goji Hasegawa; Toshikazu Yoshikawa
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

5.  Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata Study.

Authors:  Wataru Kameda; Makoto Daimon; Toshihide Oizumi; Yumi Jimbu; Minako Kimura; Akihiko Hirata; Hiroshi Yamaguchi; Hiroshi Ohnuma; Masahiko Igarashi; Makoto Tominaga; Takeo Kato
Journal:  Metabolism       Date:  2005-05       Impact factor: 8.694

6.  Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.

Authors:  A C Moses; S C Young; L A Morrow; M O'Brien; D R Clemmons
Journal:  Diabetes       Date:  1996-01       Impact factor: 9.461

7.  Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Mika Yamauchi; Soichi Kurioka; Shozo Yano; Toshitsugu Sugimoto
Journal:  Endocr J       Date:  2008-05-21       Impact factor: 2.349

8.  Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  Calcif Tissue Int       Date:  2009-07-30       Impact factor: 4.333

9.  Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1992-11-15       Impact factor: 25.391

10.  Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.

Authors:  D L Coleman; E H Leiter; R W Schwizer
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

View more
  5 in total

1.  Renaissance of acromegaly after bariatric surgery.

Authors:  Albert Lecube; Ramon Vilallonga; Giacomo Sturniolo; Gabriel Obiols; José Manuel Fort
Journal:  Endocrine       Date:  2013-02       Impact factor: 3.633

Review 2.  Dehydroepiandrosterone sulfate (DHEAS) as an endocrine marker of aging in calorie restriction studies.

Authors:  Henryk F Urbanski; Julie A Mattison; George S Roth; Donald K Ingram
Journal:  Exp Gerontol       Date:  2013-01-11       Impact factor: 4.032

3.  Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women.

Authors:  Hitomi Miyake; Ippei Kanazawa; Toshitsugu Sugimoto
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

4.  Diabetes Mellitus-induced Bone Fragility.

Authors:  Ippei Kanazawa; Toshitsugu Sugimoto
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

Review 5.  Connecting the Dots Between the Gut-IGF-1-Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis.

Authors:  Makoto Matsushita; Kazutoshi Fujita; Koji Hatano; Marco A De Velasco; Hirotsugu Uemura; Norio Nonomura
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-15       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.